
    
      To evaluate whether or not zeaxanthin supplementation raises macular pigment optical density
      (MPOD). Previous research has shown MPOD to mirror visual benefits for patients with age
      related atrophic macular degeneration (AMD) having visual symptoms (decreased visual acuity,
      contrast sensitivity, photostress glare recovery and National Eye Institute Visual Function
      Questionnaire 25 scores), but lower risk National Eye Institute (NEI) / Age Related Eye
      Disease Study (AREDS) characteristics.
    
  